MPS Reports Record Q1 FY27 Performance as Revenue Rises 20% and EBITDA Jumps 53%

What Happened ?

key details

Research Solutions:

Research Solutions remained the company’s largest business segment, supported by higher client volumes, new mandates and AI-enabled production capabilities.

Key Highlights:

• Revenue increased 13.22% YoY to ₹123.23 crore.
• Excluding AJE, revenue grew 26.33% YoY.
• EBITDA rose 37.88% YoY to ₹55.54 crore.
• EBITDA margin expanded to 45.07%.
• AI-enabled production and quality workflows were deployed across client delivery, improving productivity and operational efficiency. 

Education Solutions:

Education Solutions continued to emerge as MPS’s second major growth engine following the acquisition of Unbound Medicine.

Key Highlights

• Revenue increased 42.21% YoY to ₹73.41 crore.
• EBITDA grew 39.14% YoY to ₹25.74 crore.
• EBITDA margin remained healthy at 35.06%.
• Unbound Medicine completed its first full quarter, adding recurring, high-renewal healthcare subscription revenue.
• Headcount declined 4.26% YoY, reflecting improved operating efficiency despite higher revenue. 

Corporate Learning:

Corporate Learning delivered another quarter of improved profitability following restructuring initiatives implemented during the previous year.

Key Highlights:

• Revenue grew 6.89% YoY to ₹27.60 crore.
• EBITDA increased 60.69% YoY to ₹6.99 crore.
• EBITDA margin expanded to 25.33%, compared with 16.85% a year earlier.
• Leaner operations and new AI-led engagements contributed to stronger operating leverage.
• Growth continued across multiple geographies with new client additions.

Portfolio Diversification:

MPS continued to diversify its revenue base across business segments, customers and geographies.

Key Highlights:

• Research contributed 55.0% of total revenue.
• Education increased its contribution to 32.7% of revenue.
• Corporate Learning accounted for 12.3%.
• North America remained the largest market with 49% of revenue, followed by Europe (33%) and Rest of the World (18%). 

Customer & Operational Efficiency:

The company strengthened customer diversification while maintaining healthy working capital management.

Operational Highlights

• Number of billed clients increased to 841, compared with 404 in Q1 FY26.
• Top five customers contributed 46% of revenue.
• Debtor days (DSO) remained at 45 days, improving from 51 days in the previous quarter.
• Cash and cash equivalents stood at ₹138.02 crore, while borrowings remained low at ₹37.63 crore, supporting a strong balance sheet.

Risk Analysis

Summary:

• MPS delivered a record opening quarter, supported by strong execution across Research, Education and Corporate Learning. While profitability improved significantly through operating leverage, sustaining this momentum will depend on continued client growth, successful integration of acquisitions and maintaining high margins across business segments.

Key Risks:

• Acquisition Integration: Continued realization of synergies from the Unbound Medicine acquisition remains important for sustaining Education Solutions growth.
• Research Transition: The planned reset of the AJE business could temporarily affect reported Research segment performance, although underlying demand remains strong.
• Client Concentration: Despite higher customer diversification, a meaningful portion of revenue continues to come from large enterprise clients.
• Technology Execution: Continued investment in AI-enabled production and workflow automation is essential to maintain productivity gains and competitive positioning.
• Global Demand: Revenue remains dependent on spending by academic publishers, healthcare institutions and enterprise learning customers across international markets.

Worst Case:

• Slower integration of acquired businesses, weaker demand from research publishing customers or delays in scaling AI-enabled services could moderate revenue growth and reduce operating leverage in future quarters. 

Risk Level: Medium

Company Commentary

Management highlighted that Q1 FY27 marked the strongest opening quarter in MPS’s history and reaffirmed confidence in achieving FY27 EBITDA of more than ₹300 crore.

Management Priorities:

• Scale the Research Solutions business through new mandates and AI-enabled production.
• Expand recurring revenue in Education Solutions following the Unbound Medicine acquisition.
• Continue improving profitability in Corporate Learning through operational efficiency.
• Maintain disciplined capital allocation while preserving a strong balance sheet.
• Deliver FY27 EBITDA exceeding ₹300 crore, supported by historically stronger second-half performance.